Suchergebnisse - Laura Van't Veer

Treffer weiter einschränken
  1. 1
    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

    Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays von Kathy S. Albain, Soonmyung Paik, Laura van’t Veer

    Veröffentlicht 2009
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    The MINDACT trial: The first prospective clinical validation of a genomic tool

    The MINDACT trial: The first prospective clinical validation of a genomic tool von Fátima Cardoso, Martine Piccart, Laura Van't Veer, Emiel J. Rutgers

    Veröffentlicht 2007
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

    Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary von John Bridgewater, Ryan K. van Laar, Arno Floore, Laura van’t Veer

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity von Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

    Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma von Patti Curl, Igor Vujic, Laura van ‘t Veer, Susana Ortiz‐Urda, James G. Kahn

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein.

    TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. von Guus Hateboer, H. T. Marc Timmers, AK Rustgi, Marc Billaud, Laura van ‘t Veer, René Bernards

    Veröffentlicht 1993
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo

    E2F-5, a New E2F Family Member That Interacts with p130 In Vivo von E. Marielle Hijmans, P. Mathijs Voorhoeve, Roderick L. Beijersbergen, Laura van ‘t Veer, René Bernards

    Veröffentlicht 1995
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability

    Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability von Josien C.C. Scheepens, Laura van ‘t Veer, Laura J. Esserman, Jeffrey Belkora, Rita A. Mukhtar

    Veröffentlicht 2021
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

    Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance von Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura van ‘t Veer, Mark Jesus M. Magbanua

    Veröffentlicht 2023
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex.

    Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. von Mark J. Alkema, Marieke Bronk, Els Verhoeven, Arie P. Otte, Laura van ‘t Veer, A Berns, Maarten van Lohuizen

    Veröffentlicht 1997
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature

    Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature von Michael Knauer, Fátima Cardoso, Jelle Wesseling, Philippe L. Bédard, Sabine C. Linn, Emiel J. Rutgers, Laura van ‘t Veer

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis

    Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis von Alexandra J. van den Broek, Marjanka K. Schmidt, Laura van ‘t Veer, Rob A.�E.�M. Tollenaar, Flora E. van Leeuwen

    Veröffentlicht 2015
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Comparison of prognostic gene expression signatures for breast cancer

    Comparison of prognostic gene expression signatures for breast cancer von Benjamin Haibe‐Kains, Christine Desmedt, Fanny Piette, Marc Buyse, Fátima Cardoso, Laura van’t Veer, Martine Piccart, Gianluca Bontempi, Christos Sotiriou

    Veröffentlicht 2008
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Expression profiling predicts outcome in breast cancer

    Expression profiling predicts outcome in breast cancer von Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver, Yudong D. He, Augustinus A. M. Hart, René Bernards, Stephen Friend

    Veröffentlicht 2002
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer

    Tamoxifen resistance by a conformational arrest of the estrogen receptor α after PKA activation in breast cancer von Rob Michalides, Alexander Griekspoor, Astrid Balkenende, Desirée Verwoerd, Lennert Janssen, Kees Jalink, Arno Floore, Arno Velds, Laura van 't Veer, Jacques Neefjes

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

    N-ras mutations in human cutaneous melanoma from sun-exposed body sites. von Laura van ‘t Veer, Boudewijn Burgering, Rogier Versteeg, A J Boot, D. J. Ruiter, Susanne Osanto, Peter I. Schrier, Johannes L. Bos

    Veröffentlicht 1989
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    A protocol for building and evaluating predictors of disease state based on microarray data

    A protocol for building and evaluating predictors of disease state based on microarray data von Lodewyk F.A. Wessels, Marcel J. T. Reinders, A.A.M. Hart, Cor J. Veenman, H. Dai, Yudong D. He, Laura van ‘t Veer

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients

    Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients von James M. Ford, Sophie Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction

    A combined oncogenic pathway signature of<i>BRAF</i>,<i>KRAS</i>and<i>PI3KCA</i>mutation improves colorectal cancer classification and cetuximab treatment prediction von Sun Tian, Iris Simón, Vı́ctor Moreno, Paul Roepman, Josep Tabernero, Mireille H.J. Snel, Laura van’t Veer, Ramón Salazar, René Bernards, Gabriel Capellà

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes

    Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes von Mahasti Saghatchian, Stella Mook, Giancarlo Pruneri, Giuseppe Viale, Annuska M. Glas, Sylvie Guérin, Fátima Cardoso, Martine Piccart, Thomas Tursz, Suzette Delaloge, Laura van’t Veer

    Veröffentlicht 2013
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: